4AVR
Crystal structure of the hypothetical protein Pa4485 from Pseudomonas aeruginosa
Summary for 4AVR
| Entry DOI | 10.2210/pdb4avr/pdb |
| Descriptor | PA4485 (2 entities in total) |
| Functional Keywords | unknown function, gram-negative bacteria, infectious disease, structure-based inhibitor design |
| Biological source | PSEUDOMONAS AERUGINOSA PA01 |
| Total number of polymer chains | 2 |
| Total formula weight | 20975.79 |
| Authors | McMahon, S.A.,Moynie, L.,Liu, H.,Duthie, F.,Alphey, M.S.,Naismith, J.H. (deposition date: 2012-05-29, release date: 2013-01-09, Last modification date: 2024-05-08) |
| Primary citation | Moynie, L.,Schnell, R.,Mcmahon, S.A.,Sandalova, T.,Boulkerou, W.A.,Schmidberger, J.W.,Alphey, M.S.,Cukier, C.,Duthie, F.,Kopec, J.,Liu, H.,Jacewicz, A.,Hunter, W.N.,Naismith, J.H.,Schneider, G. The Aeropath Project Targeting Pseudomonas Aeruginosa: Crystallographic Studies for Assessment of Potential Targets in Early-Stage Drug Discovery. Acta Crystallogr.,Sect.F, 69:25-, 2013 Cited by PubMed Abstract: Bacterial infections are increasingly difficult to treat owing to the spread of antibiotic resistance. A major concern is Gram-negative bacteria, for which the discovery of new antimicrobial drugs has been particularly scarce. In an effort to accelerate early steps in drug discovery, the EU-funded AEROPATH project aims to identify novel targets in the opportunistic pathogen Pseudomonas aeruginosa by applying a multidisciplinary approach encompassing target validation, structural characterization, assay development and hit identification from small-molecule libraries. Here, the strategies used for target selection are described and progress in protein production and structure analysis is reported. Of the 102 selected targets, 84 could be produced in soluble form and the de novo structures of 39 proteins have been determined. The crystal structures of eight of these targets, ranging from hypothetical unknown proteins to metabolic enzymes from different functional classes (PA1645, PA1648, PA2169, PA3770, PA4098, PA4485, PA4992 and PA5259), are reported here. The structural information is expected to provide a firm basis for the improvement of hit compounds identified from fragment-based and high-throughput screening campaigns. PubMed: 23295481DOI: 10.1107/S1744309112044739 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.08 Å) |
Structure validation
Download full validation report
